Telemedicine-Assisted Self-Management Program for Type 2 Diabetes Patients
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Lifestyle interventions with personalized self-management programs have shown benefits for patients with type 2 diabetes mellitus (T2DM), a devastating highly prevalent disease worldwide. Despite advances in drug therapy and nonpharmacological strategies achieved in the past recent years, self-management programs to be implemented in everyday life are needed. The aim of the present prospective study was to evaluate the effects, in terms of glycated hemoglobin (HbA 1c ) values and self-management behavior, of a telemedicine-assisted self-management program offered to T2DM patients by a large private health insurance company. Methods: Participants with T2DM included 60 adults in the intervention group ( M = 59.4 years) and 55 adults in the control group ( M = 58.4 years). In the beginning of the study, the intervention group was provided with a tablet computer, a glucometer, and a step counter. Additionally, they received an individual need-based telephone coaching to address and improve motivation and diabetes self-management in daily life. The control group received care as usual and were not offered additional treatment. The study examined the results of a diabetes lifestyle program after 3 months. Results: The intervention resulted in significantly greater declines in HbA 1c compared with the control group. In addition, tele-assisted participants showed significant improvements in Diabetes Self-Management scale score and body mass index compared with usual care participants. Conclusions: Patients with T2DM can benefit from telemedicine-assisted self-management programs, which may offer new options for treatment and prevention of disease progression. More follow-up and research is needed to assess feasibility and effectiveness on a larger scale.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stages and processes of self-change of smoking: Toward an integrative model of change.
Prochaska, J. O., & DiClemente, C. C. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.51.3.390 · Cited by 9,098
Technology Acceptance Model 3 and a Research Agenda on Interventions
Venkatesh, V., & Bala, H. (2008) · Decision Sciences · doi:10.1111/j.1540-5915.2008.00192.x · Cited by 8,159 · cited 3×
“25 Additionally, two categories from previous qualitative research were added: (1) feeling of being controlled and (2) sense of security, which were not covered by the TAM3.”
InfluentialDavies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518 · cited 2×
“9 In their guidelines recommended glycemic targets are HbA 1c values 7%.”
Physical activity and reduced occurrence of non–insulin-dependent diabetes mellitus
Helmrich, S. P., Ragland, D. R., Leung, R. W., & Paffenbarger, R. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107183250302 · Cited by 1,634
Relationship between glycated haemoglobin levels and mean glucose levels over time
Nathan, D. M., Turgeon, H., & Regan, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0803-0 · Cited by 517 · cited 2×
“18 Therefore, only HbA 1c values were taken into consideration as indicator of the course of disease.”
Metabolic Syndrome, Obesity, and Mortality
Katzmarzyk, P. T., Church, T. S., Janssen, I., Ross, R., & Blair, S. N. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.391 · Cited by 378
Lee, P. A., Greenfield, G., & Pappas, Y. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3274-8 · Cited by 162
Greenwood, D. A., Young, H. M., & Quinn, C. C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813519311 · Cited by 96
Cited by
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s005 · Cited by 362
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Beverly, E. A., Bruemmer, D., Collins, B. S., Darville, A., Ekhlaspour, L., Hassanein, M., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s005 · Cited by 285
2022 National standards for diabetes self-management education and support
Davis, J., Fischl, A. H., Beck, J., Browning, L., Carter, A., Condon, J. E., Dennison, M., Francis, T., Hughes, P. J., Jaime, S., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2396 · Cited by 191
Xie, W., Dai, P., Qin, Y., Wu, M., Yang, B., & Yu, X. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-02892-1 · Cited by 182
“Most of the systematic reviews and meta-analyses on the use of telemedicine technologies for diabetes mellitus have demonstrated that TM tools could result in reduced HbA1c in individuals with type I, type II diabetes and GDM [8, 9, 13, 14, 16].”
Background2022 National standards for diabetes self-management education and support
Davis, J., Fischl, A. H., Beck, J., Browning, L., Carter, A., Condon, J. E., Dennison, M., Francis, T., Hughes, P. J., Jaime, S., et al. (2022) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106211072203 · Cited by 169
Metadata
- Authors
- von Storch, K., Graaf, E., Wunderlich, M., Rietz, C., Polidori, M. C., & Woopen, C.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2019-09-01
- Volume
- 21
- Issue
- 9
- Pages
- 514-521
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2960906136
- Cited by
- 101
- References
- 8
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.